[en] This study was designed to provide a diagnostic, symptomatologic and sanitary assessment of schizophrenic patients in the network of institutions of the Plate-Forme Psychiatrique Liegeoise (Liege, Belgium). The diagnosis of schizophrenia was based on the DSM IV. Demographic, social and global functioning (GAF scale) data were collected from the Resume Psychiatrique Minimum (RPM) , a clinical summary which has been imposed for each psychiatric hospital stay by the Belgian Ministry of Public Health. Symptoms components were derived from the Psychosis Evaluation tool for Commom Use by Caregivers (PECC). In the 44 participating institutions, 793 cases of schizophrenia were reported (533 men and 260 women) with a mean age of 46.1 14.4 years. The study confirmed the predominance of men in schizophrenia (67%) but revealed that women were about 6 years higher than men. PECC symptoms were studied in a random sample of 184 patients extracted from the 793 initial patients and analysed with respect to age, sex and type of care (full-time or part-time hospitalization, ambulatory care). Negative, cognitive and total PECC scores did not vary with sex but were positively correlated with age. Hospitalized patients were significantly older than the others. The cognitive deficit was significantly higher in hospitalized patients than in other patients, while the perception of the disease tended to be more apparent in ambulatory than in hospitalized patients. Data were also related to social information and global functioning. The GAF scores increased with age but were comparable in men and women. Moreover, GAF scores were significantly lower in catatonic type schizophrenia patients than in others.
Disciplines :
General & internal medicine
Author, co-author :
Sarto, D.
Desseilles, Michel
Martin, Michel ; Centre Hospitalier Universitaire de Liège - CHU > Exploitation technique-maintenance des bâtiments
Albert, Adelin ; Université de Liège - ULiège > Département des sciences de la santé publique > Informatique médicale et biostatistique
Language :
French
Title :
Analyse diagnostique, symptomatologique et sanitaire des patients schizophrenes en service psychiatrique liegeois
Alternative titles :
[en] Diagnostic, Symptomatic and Sanitary Assessment of Schizophrenic Patients in Liege Psychiatric Institutions
Allebeck P, Adamsson C, Engstrom A. Cannabis and schizophrenia: A longitudinal study of cases treated in Stockholm County. Acta Psychiatr Scand 1993; 88: 21-4.
Brazo P, Dollfus S. Hétérogénéité syndromique et diagnostique de la schizophrénie. Encephale 1997 (Suppl II): 20-24.
Ciompi L. The influence on aging on schizophrenia. Triangle 1993; 32 (1): 25-31.
David AS, Malmberg A, Brandt L et al. IQ and risk for schizophrenia: A population-based cohort study. Psychol Med 1997; 27: 1311-23.
De Hert M, Bussels J, Lindstrom E et al. PECC, Psychosis evaluation tool for common use by Caregivers. EPO, 1998.
De Hert M, Peuskens J. Suicide in schizophrenia. Acta Psychiatr Belg 1998 (Suppl I): 37-45.
De Hert M, Thys E, Boydens J et al. Health care expenditure on schizoprenia patients in Belgium. Schizophr Bull 1998; 24 (4): 519-27.
Ey H, Bernard P, Brisset CH. Manuel De Psychiatrie. 4e Édition. Paris: Masson, 1974.
Hafner H, An der Heiden W. Epidemiology of schizophrenia. Can J Psychiatry 1997; 42 (2): 139-51.
Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biol Psychiatry 1996; 40: 1155-63.
Hambrecht M, Maurer K, Hafner H et al. Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders. Eur Arch Psychiatry Clin Neurosc 1992; 242: 6-12.
Hughlings-Jacksons J. The factors of insanities. Medical Press and Circular 1894: 615. In: Taylor J ed. Selected Writings. London: Hodder and Stoughton, 1931.
Keith SJ, Matthews SM. The diagnosis of schizophrenia: A review of onset and duration issues. Schizophr Bull 1991; 17 (1): 51-67.
Kirchner JE, Owen RR, Nordquist C et al. Diagnosis and management of substance use disorders among inpatients with schizophrenia. Psychiatr Serv 1998; 49 (1): 82-5.
Kovess V, Pascal JC. Introduction In: Conférence de Consensus Française en Psychiatrie. Les Stratégies Thérapeutiques à Long Terme dans les Psychoses Schizophréniques. Paris: Frison-Roche, 1999: 13-34.
Lecrubier Y. Schizophrénie, de la nosographie à la dimensionnalité: Importance des données longitudinales. Encephale 1997; sp II: 39-43.
Lindström E, Von Knorring L. Principal component analysis of Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Nordic J Psychiatry 1993; 47: 257-63.
Mises R, Quemada N. Classification Française des Troubles Mentaux de l'Enfant et de l'Adolescent. Classification Internationale des Troubles Mentaux et du Comportement (Chapitre V de la CIM 10-OMS). 3e Ed. Publications du CTNERHI. Paris: Diffusion PUF, 1993.
Mullen PE, Burgess P, Wallace C et al. Community care and criminal offending in schizophrenia. The Lancet 2000; 355: 614-7.
O'Dwyer JM. Schizophrenia in people with intellectual disability: The role of pregnancy and birth complications. Jo Intell Disab Res 1997; 41 (3): 238-51.
Regier DA, Farmer ME, Rae DS. Comorbidité of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511-18.
Ribeyre JM, Dollfus S. Stabilité des symptômes positifs/négatifs des schizophrénies. Encephale 1996; sp II: 29-31.
Riecher-Rossler A, Rossler W. The course of schizophrenic psychoses: What do we really know ? A selective review from an epidemiological perspective. Eur Arch Psychiatry Clin Neurosci 1998; 248: 189-202.
Russel AJ, Munro JC, Jones DR et al. Schizophrenia and the myth of intellectual decline. Am J Psychiatry 1997; 154 (5): 635-9.
Silver H, Abboud E. Drug abuse in schizophrenia: Comparison of patients who began drug before their first admission with those began abusing drugs after their first admission. Schizophr Res 1994; 13: 57-63.
Silverstein SM. Information processing, social cognition and psychiatric rehabilitation in schizophrenia. Psychiatry 1997; 60: 327-40.
Swofford CD, Kasckow JW, Scheller-Gilkey G. Substance use: A powerful predictor of relapse in schizophrenia. Schizophr Res 1996; 20: 145-51.
Vazquez-Barquero J, Lastra I, Cuesta Nunez J et al. Patterns of positive and negative symptoms in first episode schizophrenia. Br J Psychiatry 1996; 168: 693-701.
Verdoux H, Mury M, Besancon G et al. Etude comparative des conduites toxicomaniaques dans les troubles bipolaires, schizophréniques et schizoaffectifs. Encephale 1996; XXII: 95-101.
